Skip to Main Content

Stephen L. Hauser


Neurologist and immunologist
Director, UCSF Weill Institute for Neurosciences
Immunologist seeking safe and effective treatments

Dr. Stephen L. Hauser is a neurologist, internist and immunologist who specializes in multiple sclerosis. He is director of the UCSF Weill Institute for Neurosciences and an international leader in research on the genetic basis, immune mechanisms and treatment of MS. Hauser identified the benefit of immunosuppression to prevent the body from attacking the myelin sheath, the insulation surrounding nerves in the brain and spinal cord. He also demonstrated the benefit of MS treatments directed against B lymphocytes, a type of immune cell.

Hauser earned his medical degree at Harvard Medical School. He trained in internal medicine at New York–Presbyterian Hospital/Weill Cornell Medical Center, in neurology at Massachusetts General Hospital, and in immunology at Harvard Medical School and the Pasteur Institute.

Hauser has received numerous awards and honors, including an appointment by President Barack Obama as an adviser on issues emerging from advances in biomedicine and related areas of science and technology. He is a fellow of the Association of American Physicians and American Academy of Arts and Sciences, and a member of the National Academy of Medicine. He is also a former president of the American Neurological Association and an editor of the textbook "Harrison's Principles of Internal Medicine." He speaks French.

  • Education

    Harvard University School of Medicine, 1975

  • Residencies

    New York–Presbyterian Hospital/Weill Cornell Medical Center, Internal Medicine, 1978

  • Fellowships

    Massachusetts General Hospital, Neurology, 1980

  • Board Certifications

    Neurology, American Board of Psychiatry and Neurology.

    Internal Medicine, American Board of Internal Medicine

  • Academic Title


  • Languages


We are at the threshold of a new era in which we will prevent and repair damage to the nervous system, and the Weill Institute is poised to play a major role.

Where I see patients (1)